Reihaneh Alsadat Mahmoudian

Dr. Reihaneh Alsadat Mahmoudian


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2023 in Pathology - Research and Practice
Verified
Journal Article
Closed access
RMReihaneh Alsadat Mahmoudian
Reihaneh Alsadat Mahmoudian
IAIman Akhlaghipour
Iman Akhlaghipour
MLMalihe Lotfi
Malihe Lotfi
SSSoodabeh Shahidsales
Soodabeh Shahidsales
MMMeysam Moghbeli
Meysam Moghbeli

23 July 2024 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
MSMaryam Sadri
Maryam Sadri
SHSahel Heidari
Sahel Heidari
AFArezoo Faridzadeh
Arezoo Faridzadeh
MRMona Roozbehani
Mona Roozbehani
STShirin Toosi
Shirin Toosi
FFFatemeh Faraji
Fatemeh Faraji
Immunotherapy has improved cancer treatment based on investigations of tumor immune escape. Manipulation of the immune system stimulates antitumor immune responses and blocks tumor immune escape routes. Genetically adoptive cell therapy, such as T cells, has yielded promising results for hematologic malignancies, but their application to solid tumors has been challenging. Macrophages have a wide broad of capabilities in regulating immune responses, homeostasis, and tissue development, as well as the ability to phagocyte, present antigens, and infiltrate the tumor microenvironment (TME). Given the importance of macrophages in cancer development, they could serve as novel tool for tumor treatment. Therefore, macrophages are used in different formats for direct and indirect targeting of tumor cells. This review summarized the available data on the various applications of macrophages in cancer immunotherapy.

1 September 2021 in Experimental Cell Research
Verified
Journal Article
Closed access
RMReihaneh Alsadat Mahmoudian
Reihaneh Alsadat Mahmoudian
MFMoein Farshchian
Moein Farshchian
MAMohammad Reza Abbaszadegan
Mohammad Reza Abbaszadegan

18 April 2024 in BMC Public Health
Verified
Journal Article
Open access
PDF file
MVMohammad Moein Vakilzadeh
Mohammad Moein Vakilzadeh
RKReza Khayami
Reza Khayami
DDDanyal Daneshdoust
Danyal Daneshdoust
RMReza Moshfeghinia
Reza Moshfeghinia
FSFarzad Sharifnezhad
Farzad Sharifnezhad
RMReihaneh Alsadat Mahmoudian
Reihaneh Alsadat Mahmoudian
Background: The prevalence of tobacco use among various cancer types in Iran remains a significant concern, necessitating a comprehensive analysis to understand the extent and patterns of consumption. This study aimed to systematically review and analyze existing literature to delineate the prevalence of tobacco use across different cancer types in Iran, thereby providing a robust basis for future interventions and policy formulations. Methods: Adhering to the PRISMA guidelines, we conducted a systematic review and meta-analysis of literature available in PubMed and Scopus databases. The initial search identified 351 records, out of which 44 studies were selected based on their relevance and design. These studies spanned various time frames, starting from the 2001s up until 2022, and encompassed diverse geographical locations and cancer types in Iran. To avoid bias and potential data overlap, we opted to incorporate a single comprehensive study from the Golestan Cohort, encompassing all data, while excluding 10 other studies. Our final analysis incorporated data from 34 studies, which accounted for 15,425 patients and 5,890 reported smokers. Statistical analyses were performed to calculate the overall proportion of tobacco consumption and to conduct subgroup analyses based on different variables such as cancer types, gender, geographical locations, and types of tobacco used. Results: The analysis revealed a substantial prevalence of tobacco use among cancer patients in Iran, with an overall consumption rate of 43%. This rate varied significantly, ranging from 10 to 88% across individual studies. Subgroup analyses further highlighted disparities in tobacco consumption rates across different demographics, geographic areas, and cancer types. Notably, the ‘ever’ smokers category exhibited the highest prevalence of tobacco use. The study also identified a worrying trend of high cigarette smoking rates, along with variable consumption patterns of other forms of tobacco, including waterpipe, ‘Naas’, and ‘Pipe’. Conclusions: This systematic review and meta-analysis underscores a significant association between tobacco consumption and various cancer types in Iran, with a prevalence rate among cancer patients being three times higher than the average Iranian population. The findings indicate substantial heterogeneity in tobacco use patterns, emphasizing the need for targeted interventions to address this pressing health issue. The study serves as a critical resource for shaping future policies and strategies aimed at curbing tobacco use and mitigating its adverse effects on cancer prevalence in Iran.

5 October 2022 in Molecular and Cellular Probes
Verified
Journal Article
Closed access
NTNegin Taghehchian
Negin Taghehchian
MFMoein Farshchian
Moein Farshchian
RMReihaneh Alsadat Mahmoudian
Reihaneh Alsadat Mahmoudian
AAAhmad Asoodeh
Ahmad Asoodeh
MAMohammad Reza Abbaszadegan
Mohammad Reza Abbaszadegan